Intriguingly, heterozygous Kmt2d+/− mice exhibit metabolic alterations consisting of enhanced glucose tolerance, insulin sensitivity, and increased serum bile acid [12] as well as resistance to over-nutrition-induced hepatic steatosis [13]. This evidence concerns the gene INS and fatty liver disease.